Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDNeurogene Inc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 5 | -$1.61 | -$0.96 | -$1.30 |
| Q2 2026 | 5 | -$1.80 | -$1.25 | -$1.43 |
| Q3 2026 | 5 | -$1.75 | -$1.05 | -$1.37 |
| Q4 2026 | 1 | -$1.40 | -$1.40 | -$1.40 |
| Q1 2027 | 1 | -$1.47 | -$1.47 | -$1.47 |
| Q2 2027 | 1 | -$1.50 | -$1.50 | -$1.50 |
| Q3 2027 | 1 | -$1.53 | -$1.53 | -$1.53 |
| Q4 2027 | 1 | -$1.58 | -$1.58 | -$1.58 |
Neurogene Inc Earnings Date And Information
Neurogene Inc last posted its earnings results on Tuesday, May 12th, 2026. The company reported $-1.39 earnings per share for the quarter, missing analysts' consensus estimates of $-1.29625 by $0.09375. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Neurogene Inc has generated $-4 earnings per share over the last year ($-4.24 diluted earnings per share) and currently has a price-to-earnings ratio of -6.41. Neurogene Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Neurogene Inc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 05/12/2026 | Q1 2026 | -$1.30 | -$1.39 | -0.09 | $0 | $0 |
| 03/24/2026 | Q4 2025 | -$1.24 | -$1.60 | -0.36 | $0 | $0 |
| 11/13/2025 | Q3 2025 | -$1.26 | -$0.99 | 0.27 | $0 | $0 |
| 08/11/2025 | Q2 2025 | -$1.15 | -$1.05 | 0.1 | N/A | $0 |
| 05/09/2025 | Q1 2025 | -$1.05 | -$1.08 | -0.03 | N/A | $0 |
| 03/24/2025 | Q4 2024 | -$1.04 | -$1.31 | -0.27 | N/A | $0 |
| 11/18/2024 | Q3 2024 | -$1.22 | -$1.19 | 0.03 | N/A | $0 |
| 08/09/2024 | Q2 2024 | -$1.02 | -$1.09 | -0.07 | N/A | $925.00 K |
| 05/10/2024 | Q1 2024 | -$1.03 | -$1.00 | 0.03 | N/A | $0 |
| 03/18/2024 | Q4 2023 | N/A | -$1.21 | N/A | N/A | $0 |
| 09/29/2023 | Q3 2023 | N/A | -$0.41 | N/A | N/A | $0 |
| 06/29/2023 | Q2 2023 | N/A | -$0.21 | N/A | N/A | $0 |
| 03/29/2023 | Q1 2023 | N/A | -$0.26 | N/A | N/A | $0 |
| 12/29/2022 | Q4 2022 | N/A | -$0.32 | N/A | N/A | $0 |
| 09/29/2022 | Q3 2022 | N/A | -$2.36 | N/A | N/A | $0 |
| 06/28/2022 | Q2 2022 | N/A | -$0.28 | N/A | N/A | $0 |
| 03/30/2022 | Q1 2022 | N/A | -$0.28 | N/A | N/A | $0 |
| 12/29/2021 | Q4 2021 | N/A | -$0.36 | N/A | N/A | $0 |
| 09/28/2021 | Q3 2021 | N/A | -$0.28 | N/A | N/A | $0 |
| 06/28/2021 | Q2 2021 | N/A | -$0.27 | N/A | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Neurogene Inc Earnings: FAQ's
The conference call for Neurogene Inc's latest earnings report can be listened to online.
The conference call transcript for Neurogene Inc's latest earnings report can be read online.
Neurogene Inc (:NGNE) has a recorded net income of $-90,351,000.Neurogene Inc has generated $-4.24 earnings per share over the last four quarters.
Neurogene Inc (:NGNE) has a price-to-earnings ratio of -6.41 and price/earnings-to-growth ratio is 0.79.